Chemoinformaics analysis of 3,4,5-Trimethoxybenzoic acid
| Molecular Weight | 212.201 | nRot | 4 |
| Heavy Atom Molecular Weight | 200.105 | nRig | 7 |
| Exact Molecular Weight | 212.068 | nRing | 1 |
| Solubility: LogS | -2.269 | nHRing | 0 |
| Solubility: LogP | 1.6 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 28.7115 |
| nHD | 1 | BPOL | 18.1145 |
| QED | 0.817 |
| Synth | 1.608 |
| Natural Product Likeliness | 0.328 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.843 |
| MDCK | 0.0000133 |
| BBB | 0.756 |
| PPB | 0.318197 |
| VDSS | 0.392 |
| FU | 0.459799 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.941 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.082 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.242 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.114 |
| CL | 6.75 |
| T12 | 0.932 |
| hERG | 0.058 |
| Ames | 0.009 |
| ROA | 0.017 |
| SkinSen | 0.157 |
| Carcinogencity | 0.042 |
| EI | 0.948 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.043 |
| Antiviral | No |
| Prediction | 0.87786 |